Triple
T10610087
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | rimonabant |
E275982
|
entity |
| Predicate | hasTradeName |
P24555
|
FINISHED |
| Object |
Acomplia
Acomplia is the brand name for rimonabant, a cannabinoid receptor antagonist that was developed as an anti-obesity drug but withdrawn due to psychiatric side effects.
|
E874318
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69d6aaf948d88190806cc3a8c47a3fb2 |
elicitation | completed |
| NER | batch_69d6df59468881909b0c67d3f08c4b76 |
ner | completed |
| NED1 | batch_69d95ebe539881908aeff1cd65cf925f |
ned_source_triple | completed |
| NED2 | batch_69d961047a78819088094e02c0b99f60 |
ned_description | completed |
| NEDg | batch_69d95f81955c8190b629d57a034a4b76 |
nedg | completed |
Created at: April 8, 2026, 7:32 p.m.